Fate Therapeutics
FATE
#8488
Rank
C$0.21 B
Marketcap
$1.85
Share price
-2.92%
Change (1 day)
-71.79%
Change (1 year)

P/S ratio for Fate Therapeutics (FATE)

P/S ratio as of April 2025 (TTM): 11.6

According to Fate Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.4962. At the end of 2024 the company had a P/S ratio of 13.5.

P/S ratio history for Fate Therapeutics from 2013 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202413.5131.76%
20235.80-42.99%
202210.2-89.82%
2021100-60.36%
202025281.87%
2019139-20.75%
2018175123.55%
201778.3231.94%
201623.6-40.72%
201539.8
2014N/A-100%
2013132

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
3.04-73.83%๐Ÿ‡บ๐Ÿ‡ธ USA
2.83-75.63%๐Ÿ‡บ๐Ÿ‡ธ USA
4.86-58.10%๐Ÿ‡บ๐Ÿ‡ธ USA
347 2,893.12%๐Ÿ‡บ๐Ÿ‡ธ USA
4.36-62.46%๐Ÿ‡บ๐Ÿ‡ธ USA